Na+,
Numerous studies have indicated that plasma volume expansion or an increased intake of sodium causes a natriuresis and enhances vascular reactivity (de Wardener and Clarkson, 1985) . These phenomena are thought to be due to an endogenous sodium-potassium activated adenosine 5'-triphosphatase (Nat, K+-ATPase) inhibitor which inhibits the Na+-K+ pump in renal tubular cells and vascular smooth muscle cells (Haddy and Overbeck, 1976; Blaustein, 1977; de Wardener and MacGregor, 1980) . Since an endogenous Nat, K+-ATPase inhibitor is postulated to play a physiological role in the control of sodium balance and blood pressure, a number of laboratories have made concerted efforts to isolate and identify this substance (Haber and Haupert, 1987) . However, there is disagreement concerning the chemical nature, whether peptides (Gruber et al., 1980; Kramer et al., 1985; Morgan et al., 1985) , steroids (Cloix et al., 1985; Vasdev et al., 1985) or lipid compounds (Tamura et al., 1985; Kelly et al., 1986) . The conflicting results may be due to various relevant and irrelevant substances. In order to elucidate the Nat, K+-ATPase inhibitor(s) which plays a physiological role in the control of sodium balance, the present study was designed to investigate the effect of changes in dietary sodium intake on daily Nat, K+-ATPase inhibitory activity in the urine of normal subjects, which was fractionated by high performance liquid chromatography (HPLC). We also investigated Nat, K+-ATPase inhibitory activity in pooled serum of normal subjects, which was fractionated by the same HPLC. 100
The coefficient of variation on % inhibition against ouabain was below 2.0%. unit and injected onto the same Shimpak-PREP-ODS column.
The column was eluted with a linear 0-40% acetonitrile gradient in 40 min, at a flow rate of 5ml/min.
Fractions were collected every 5 min. Equal number fractions from different injections were combined and evaporated. Nat, K+-ATPase inhibitory activity of each fraction was tested.
Other assays
Nonesterified fatty acid and phospholipid were measured enzymatically with commercially available kits (NEFA-E, Iatron Laboratories, Inc., Tokyo, Japan and Sanassay PL, Sanko Junyaku Co., Ltd., Tokyo, Japan) using a centrifugal analyzer. The sodium concentration was determined by flame photometry.
Fig.1. Elution profile of
Na-, K--ATPase inhibitory activity and digoxin-like immunoreactivity from urine on a Shimpak PREP-ODS column. Urine extract obtained from a SepPak C18 cartridge was fractionated by reverse phase HPLC using a linear gradient of acetonitrile (0-40%) in water.
Statistical evaluation
Results were expressed as means+ S. D.. For statistical analysis of data, the paired Student's t-test was used.
Results

Nat, K+-A TPase inhibitory activity
and digoxin-like immunoreactivity in fractionated urine An elution profile of Nat, K+-ATPase inhibitory activity and digoxin-like immunoreactivity in urine extract obtained from by reverse phase HPLC is shown in Fig.1 . Three peaks (fractions 8, 10 and 12-13) which inhibited Nat, K+-ATPase and one broad peak (Fraction 9-14) which crossreacted with anti-digoxin antibody were observed. Although fraction 10 and fraction 12-13 inhibited Nat, K+-ATPase as well as crossreacting with anti-digoxin antibody, fraction 8 did not cross-react with antidigoxin antibody.
2. Nat, K+-A TPase inhibitory activity of fractionated urine and urinary sodium excretion during changes in dietary sodium intake. An example of chromatographic patterns in one subject during changes in dietary sodium intake is shown in Fig.2 . The Nat, K+-ATPase inhibitory activity of fraction 10 eluted with about 17% acetonitrile decreased with low sodium intake, increased with high sodium intake, and decreased again with low sodium intake, indicating that changes in the Nat, K+-ATPase inhibitory activity of fraction 10 were closely associated with the changes in dietary sodium intake. There was no significant correlation between Nat, K+-ATPase inhibitory activity in other fractions and dietary sodium intake.
The Nat, K+-ATPase inhibitory activity of fraction 10 and urinary sodium excretion in 7 normal subjects during changes in dietary sodium intake are shown in Fig.3 sodium diet and on the 1st day of the normal sodium diet was significantly higher than that of the control(p<0.01).
3. Digoxin-like immunoreactivity in urine extract during changes in dietary sodium intake.
Digoxin-like immunoreactivity in urine extract of 7 normal subjects during alteration of dietary sodium intake is shown in Fig.  4 . Although there was a small reduction in the digoxin-like immunereactivity towards the end of the low sodium intake period and a small increase towards the end of the high sodium intake period, their changesa were not statistically significant as compaired with the control.
Nat, K+-A TPase inhibitory in fractionated serum
There were at least 4 peaks containing Nat, K+-ATPase inhibitory activity in serum extract obtained from reversephase HPLC, one of which consisted of fraction 10 eluted at about a 17% acetonitrile concentration (Fig.  5) . Only fraction 17-19 contained either nonesterified fatty acid or phospholipid.
Discussion
The present study clearly demonstrated that the Nat, K+-ATPase inhibitory activity of fraction 10 in the urine of normal subjects which was eluted with 17% acetonitrile concentration can be influenced by changes in dietary sodium intake. In particular, it de- Elution profile of Na-, K--ATPase inhibitory activity from serum on a Shimpak PREP-ODS column. Serum extract obtained from dialysate was fractionated by reverse-phase HPLC using a linear gradient of acetonitrile (0-40%) in water. changes in Nat, K+-ATPase inhibitory activity in fraction 10 and those in urinary sodium excretion clearly suggested that a Nat, K+-ATPase inhibitor(s) present in fraction 10 may play a physiological role in the control of sodium balance. An endogenous N+, K+-ATPase inhibitor is thought to possess digoxin.-like properties with respect to its ability to inhibit Nat, K+-ATPase. Gruber et al.(1980) showed immunological cross-reactivity with digitalis in the plasma of volume expanded dogs. Klingmuller et al.(1982) found digitalislike immunoreactivity in the urine of sodium loaded normal human subjects. However, recent studies Kramer et al., 1985) have shown a lack of correlation between the digoxin-like immunoreactivity and either sodium intake or total natriuretic activity by bioassay. The present results showing dissociation of digoxin-like immunoreactivity from Nat, K+-ATPase inhibitory activity in fractionated urine and a lack of increased digoxin-like immunoreactivity in crude urine extract during high sodium intake are in agreement with these studies. The Nat, K+-ATPase inhibitory activity and the digoxin-like immunoreactivity in fraction 10 may not be the same moiety. Further analysis with different antibodies to digitalis derivatives will be needed to determine whether a Nat, K+-ATPase inhibitor possesses digoxin-like immunoreactivity.
We investigated Nat, K+-ATPase inhibitory activity in pooled serum from normal subjects by using the same HPLC. The serum extract was resolved into at least 4 peaks containing Nat, K+-ATPase inhibitory activity, one of which consisted of fraction 10. We could not determine which individual serum peaks with Nat, K+-ATPase inhibitory activity rose with salt loading, since it was difficult to obtain an adequate amount of serum to quantify from individual subjects.
The peak consisting of fraction 10 might rise with salt loading, taking into account the result of urine. Further purification of serum and urine will be needed to determine whether the substance in fraction 10 of serum which inhibits Nat, K+-ATPase is identical with that in urine. Tamura et al.(1985) reported that linoleic and oleic acids were detected as Nat, K+-ATPase inhibitors in saline-infused hog plasma. Kelly et al.(1986) also reported that a major component of plasma Nat, K+-ATPase inhibitory activity is due to nonesterified fatty acids and lysophospholipids. However, they were not thought to be physiological regulators of Nat, K+-ATPase because of their limited affinity and specificity. To eliminate these lipid compounds liberated by boiling, we used serum extract obtained from dialysate for chromatographic procedure. Indeed, fraction 10 of serum contained neither nonesterified fatty acid nor phospholipid.
In summary, the present study clearly demonstrates that Nat, K+-ATPase inhibitory activity in the particular fraction can be modulated by changes in dietary sodium intake, suggesting that a Nat, K+-ATPase inhibitor(s) which might be important in salt and volume homeostasis may exist in man.
